The ASKA Group Seeks to Realize Sustainable Growth and Social Contributions
Sustainability
Based on our corporate philosophy—to contribute toward the improvement of people’s health and progress in medicine through the development of innovative products—the entire ASKA Group seeks to create sustainable growth and to make social contributions. We will also enhance profitability through sound business activities rooted in the trust of our stakeholders and will fulfill our social responsibilities as a good corporate citizen.
Back Issues
Top Commitment
Top commitment message from President and Representative Director, Takashi Yamaguchi
Our Basic Policy for Sustainability
The Company's basic policy for our sustainability
Materiality
The company’s materiality is posted.
Value Creation Process
Through a cycle of value creation, we will contribute to solving social issues in the healthcare field.
Capital and Strengths
We aim to create a virtuous cycle where the enhancement of manufactured, intellectual, natural, social and relationship, and human capital drives the growth of financial capital.
Initiatives for Sustainability and SDGs
Based on the role ASKA Pharmaceutical Holdings should fulfill, we will work on the following nine priority goals from among the 17 SDGs (Sustainable Development Goals).
Importance of Female Healthcare and Social Issues
Importance of Female Healthcare and Social Issues Our Social Impact
Disclosures based on TCFD recommendations
The Company considers the issue of climate change as a one of the management issues that affects its business and is committed to climate change measures
Disclosures based on TNFD recommendations
Recognizing that the burden of environmental impacts from our business activities affects biodiversity, the Company is working to reduce various environmental burdens.
Environmental
The Group is committed to protecting the environment and reducing its impact across all areas of its business, contributing to resolving global environmental issues and realizing a sustainable society.
Social
The Group's belief is that they should not only provide superior pharmaceutical products through their business activities but also recognize and contribute to solving various issues as a responsible member of society. Moreover, the Company intends to actively participate in social contribution activities as a good corporate citizen, apart from contributing to society through their business activities.
Governance
The Group's objective is to attain sustainable growth for the Company and its subsidiaries while improving its corporate value in the medium to long term. To achieve this goal, the Group is consistently working on establishing and reinforcing a robust and influential corporate governance system.
ESG Chart
ESG Data Book
External Evaluation
Initiatives and Main Organizations
Third-party Opinion
Sustainability News
The latest initiatives related to sustainability are posted here.
Various Contrasting Tables
This is a comparison table of sustainability-related information and various guidelines. It includes information on ISO 26000, GRI Standards, the UN GC, and the SDGs.
Policies
Various policies are posted.
Ratio of female employees*1
33.5％
Ratio of female management positions
13.5％
Ratio of female management candidates
20.0％
(End of FY2024 in ASKA Pharmaceutical)
Initiatives to Promote the Advancement of Women
100.0％
（FY2024 in ASKA Pharmaceutical)
53.6％
* The rate in FY2024 compared with the rate in FY2013
Decarbonization Initiatives
For viewing Size: A3[PDF]
For Printing Size: A4[PDF]
Download individually
Introduction
Value Creation Story
Explanation of Strategy
Foundation for Value Creation
Data Section
Inquiries about our sustainability
For inquiries for our sustainability, please use the following telephone or inquiry form. *Depending on the content of your inquiry, we may not be able to reply.